Skip to content
★ Sign in to follow
CP

Cachet Pharmaceutical Co., Ltd. Stock: price and insider trades · China

嘉事堂

CN·Mcap CN¥3.5BHealth Care

Cachet Pharmaceutical Co., Ltd.: what insiders have been doing

Only a handful of insider records exist for Cachet Pharmaceutical Co., Ltd., the last one from 28 January 2022, too few to describe a trend. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€82,839
1 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 16,820 of 26,897 companies
43.6
score / 100
Value
65
Quality
23
FCF yld40%
Earn yld3.2%
EV/EBITDA11.8x
ROE0.9%
Gross mgn6.4%
Net mgn0.6%
Debt/EBITDA4.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥11.84
Analyst consensus
·
Income statement
RevenueCN¥19.5B
Gross profitCN¥1.2B6% margin
EBITDACN¥448M2% margin
Net incomeCN¥111.4M0.5% margin
Valuation
PER (trailing)38.2x
P/Book0.8x
Beta0.35
Balance sheet & cash
Market capCN¥3.5B
Total debtCN¥1.8B
Free Cash FlowCN¥1.4B
Debt / Equity27%
Profitability & ownership
ROE0.9%
ROA1.4%
% insiders42.2%
% institutions0.1%
Last declaration on 28 January 2022
Declarations1 total
  • ▼
    董事Executives
    588,800 CNY15SZSE
    46,000 shares100.0% of flowA股XSHESZSE:173000005271404220

1 of 1 declaration

About Cachet Pharmaceutical Co., Ltd.

嘉事堂 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It specializes in the research and development of pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations